Variation in prescribing of lipid-lowering medication in primary care is associated with incidence of cardiovascular disease and all-cause mortality in people with screen-detected diabetes: findings from the ADDITION-Denmark trial

AIMS: To examine variation between general practices in the prescription of lipid-lowering treatment to people with screen-detected Type 2 diabetes, and associations with practice and participant characteristics and risk of cardiovascular events and all-cause mortality. METHODS: Observational cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Simmons, R K, Carlsen, A H, Griffin, S J, Charles, M, Christiansen, J S, Borch-Johnsen, K, Sandbæk, A, Lauritzen, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Ltd 2014
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283975/
https://www.ncbi.nlm.nih.gov/pubmed/25185778
http://dx.doi.org/10.1111/dme.12574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283975/
https://www.ncbi.nlm.nih.gov/pubmed/25185778
http://dx.doi.org/10.1111/dme.12574

Ejemplares similares